First Stage Investor

New Recommendation: 20/20 GeneSystems

New Recommendation: 20/20 GeneSystems
By Andy Gordon
Date December 11, 2017
Share
Deal Details Security Type: Preferred Stock Round Size: Up to $1.07 million Price per Share: $3.26 Valuation cap: $23 million Deadline: Midnight (PT) on Thursday, December 14 Investment portal: MicroVentures Liquidation preference: Pari passu with other series of preferred stock and senior to the common…
Early Investing

First Stage Investor

Sign up to view this First Stage Investor article

Become a smarter investor! Discover new investment opportunities and get the latest market research, trends and analysis in startups, crypto and cannabis.

Sign up today

Top Posts on Early Investing

Crypto Monitor: A Victory for Crypto in China and Hong Kong

China has a complicated relationship with crypto. The Chinese government continues to promote the use and development of blockchain, but crypto trading is still banned in mainland China.…

Bitcoin Decouples From Stocks, Moves Closer to Gold

Crypto Market Musings It’s been a relatively calm week for crypto. Bitcoin is up 1.73% over the last seven days as of this writing. Ethereum is up 3.54%…

New Pick: A Hidden Treasure in the Plant-Based Meat Market

Editor’s Note: This recommendation was co-authored by KingsCrowd Investment Research Manager Olivia Strobl. Mmmm, pizza.